Effects of the baseline prognostic factors on efficacy of the p62/SQSTM1-encoding plasmid combined with gemcitabine in patients with recurrent platinum-resistant ovarian cancer.

Alexander Shneider, Sergey Polyakov,Yauheni Baranau, Vlad Gabai, Ekaterina Zharkova, Olga Streltsova, Aliona Filimonava, Volha Siarheyeva, Sviatlana Kazlouskaya, Anton Khorau,Bhavana Pothuri, Sergei Krasny

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览3